论文部分内容阅读
目的观察黄芪注射液治疗儿童病毒性心肌炎的临床疗效。方法 88例心肌炎患儿随机分为对照组和治疗组,对照组给予辅酶A、ATP、肌苷、大剂量维生素C以及含镁极化液等治疗,并及时抗感染、控制心衰、纠正心律失常等。治疗组在对照组基础上给予黄芪注射液治疗。结果经治疗1个疗程后,对照组总有效率79.55%,治疗组总有效率95.45%。结论使用黄芪注射液治疗儿童病毒性心肌炎疗效满意,无明显不良反应,值得临床推广应用。
Objective To observe the clinical efficacy of Astragalus injection in the treatment of viral myocarditis in children. Methods 88 children with myocarditis were randomly divided into control group and treatment group. The control group was treated with coenzyme A, ATP, inosine, high-dose vitamin C and magnesium-containing polarization solution, anti-infection, heart failure control, Disorders and so on. The treatment group was given astragalus injection on the basis of the control group. Results After a course of treatment, the total effective rate of the control group was 79.55%, and the total effective rate of the treatment group was 95.45%. Conclusion Astragalus injection treatment of children with viral myocarditis satisfactory results, no significant adverse reactions, it is worth promoting the clinical application.